These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells. Cordero-Herrera I; Martín MA; Bravo L; Goya L; Ramos S Nutr Cancer; 2013; 65(5):718-28. PubMed ID: 23859040 [TBL] [Abstract][Full Text] [Related]
23. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis. Kariya Y; Kihara A; Ikeda M; Kikuchi F; Nakamura S; Hashimoto S; Choi CH; Lee YM; Igarashi Y Genes Cells; 2005 Jun; 10(6):605-15. PubMed ID: 15938718 [TBL] [Abstract][Full Text] [Related]
24. Lyase to live by: sphingosine phosphate lyase as a therapeutic target. Kumar A; Saba JD Expert Opin Ther Targets; 2009 Aug; 13(8):1013-25. PubMed ID: 19534571 [TBL] [Abstract][Full Text] [Related]
26. S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling. Kumar A; Zamora-Pineda J; Degagné E; Saba JD Mediators Inflamm; 2017; 2017():7685142. PubMed ID: 29333002 [TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells. Liu HF; Hu HC; Chao JI Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607 [TBL] [Abstract][Full Text] [Related]
28. Molecular basis for the tissue specificity of β-catenin oncogenesis. Sharma A; Sen JM Oncogene; 2013 Apr; 32(15):1901-9. PubMed ID: 22689057 [TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate-lyase deficiency affects glucose metabolism in a way that abets oncogenesis. Afsar SY; Alam S; Fernandez Gonzalez C; van Echten-Deckert G Mol Oncol; 2022 Oct; 16(20):3642-3653. PubMed ID: 35973936 [TBL] [Abstract][Full Text] [Related]
30. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme. Ikeda M; Kihara A; Kariya Y; Lee YM; Igarashi Y Biochem Biophys Res Commun; 2005 Apr; 329(2):474-9. PubMed ID: 15737611 [TBL] [Abstract][Full Text] [Related]
31. Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy. Kageyama Y; Uranbileg B; Kusumoto Y; Sakai E; Ikeda H; Kurano M; Yatomi Y Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32614038 [TBL] [Abstract][Full Text] [Related]
32. Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression. de la Garza-Rodea AS; Baldwin DM; Oskouian B; Place RF; Bandhuvula P; Kumar A; Saba JD FASEB J; 2014 Jan; 28(1):506-19. PubMed ID: 24158395 [TBL] [Abstract][Full Text] [Related]
33. Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells. Lamy V; Bousserouel S; Gossé F; Minker C; Lobstein A; Raul F Oncol Rep; 2011 Jul; 26(1):109-14. PubMed ID: 21519792 [TBL] [Abstract][Full Text] [Related]
34. Heterogeneous sphingosine-1-phosphate lyase gene expression and its regulatory mechanism in human lung cancer cell lines. Ito H; Yoshida K; Murakami M; Hagiwara K; Sasaki N; Kobayashi M; Takagi A; Kojima T; Sobue S; Suzuki M; Tamiya-Koizumi K; Nakamura M; Banno Y; Nozawa Y; Murate T Biochim Biophys Acta; 2011 Mar; 1811(3):119-28. PubMed ID: 21184844 [TBL] [Abstract][Full Text] [Related]
35. 5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells. Can G; Akpinar B; Baran Y; Zhivotovsky B; Olsson M Oncogene; 2013 Sep; 32(38):4529-38. PubMed ID: 23108402 [TBL] [Abstract][Full Text] [Related]
36. Gene therapy with AAV9-SGPL1 in an animal model of lung fibrosis. Bhattacharyya A; Khan R; Lee JY; Tassew G; Oskouian B; Allende ML; Proia RL; Yin X; Ortega JG; Bhattacharya M; Saba JD J Pathol; 2024 May; 263(1):22-31. PubMed ID: 38332723 [TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues. Borowsky AD; Bandhuvula P; Kumar A; Yoshinaga Y; Nefedov M; Fong LG; Zhang M; Baridon B; Dillard L; de Jong P; Young SG; West DB; Saba JD J Lipid Res; 2012 Sep; 53(9):1920-31. PubMed ID: 22781001 [TBL] [Abstract][Full Text] [Related]
38. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling. Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514 [TBL] [Abstract][Full Text] [Related]
39. Recent Insight into the Role of Sphingosine-1-Phosphate Lyase in Neurodegeneration. Wieczorek I; Strosznajder RP Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047151 [TBL] [Abstract][Full Text] [Related]
40. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. Bandhuvula P; Saba JD Trends Mol Med; 2007 May; 13(5):210-7. PubMed ID: 17416206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]